Response adaptive randomization procedures in seamless phase II/III clinical trials

References

• Andersen, J. 1996. Clinical trials designs–made to order. Journal of Biopharmaceutical Statistics 6:515–522. doi:10.1080/10543409608835159.
   PubMedGoogle Scholar
• Antognini, A. B., and A. Giovagnoli. 2010. Compound optimal allocation for individual and collective ethics in binary clinical trials. Biometrika 97 (4):935–946. doi:10.1093/biomet/asq055.
   Web of Science ®Google Scholar
• Atkinson, A. C., and A. Biswas. 2005. Bayesian adaptive biased-coin designs for clinical trials with normal responses. Biometrics 61 (1):118–125. doi:10.1111/j.0006-341X.2005.031002.x.
   PubMed Web of Science ®Google Scholar
• Barnes, P. J., S. J. Pocock, H. Magnussen, A. Iqbal, B. Kramer, M. Higgins, and D. Lawrence. 2010. Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design. Pulmonary Pharmacology and Therapeutics 23 (3):165–171. doi:10.1016/j.pupt.2010.01.003.
   PubMed Web of Science ®Google Scholar
• Bauer, P., F. Koenig, W. Brannath, and M. Posch. 2010. Selection and bias-two hostile brothers. Statistics in Medicine 29 (1):1–13. doi:10.1002/sim.3716.
   PubMed Web of Science ®Google Scholar
• Bauer, P., and K. Köhne. 1994. Evaluation of experiments with adaptive interim analyses. Biometrics 1029–1041. doi:10.2307/2533441.
   PubMed Web of Science ®Google Scholar
• Bauer, P., and M. Kieser. 1999. Combining different phases in the development of medical treatments within a single trial. Statistics in Medicine 18 (14):1833–1848.
   PubMed Web of Science ®Google Scholar
• Berry, D. A. 2004. Bayesian statistics and the efficiency and ethics of clinical trials. Statistical Science 19 (1):175–187. doi:10.1214/088342304000000044.
   Web of Science ®Google Scholar
• Berry, D. A. 2012. Adaptive clinical trials in oncology. Nature Reviews Clinical Oncology 9 (4):199–207. doi:10.1038/nrclinonc.2011.165.
   Web of Science ®Google Scholar
• Bhatt, D. L., and C. Mehta. 2016. Adaptive designs for clinical trials. New England Journal of Medicine 375 (1):65–74. doi:10.1056/NEJMra1510061.
   PubMed Web of Science ®Google Scholar
• Biswas, A., S. Mandal, and R. Bhattacharya. 2011. Multi-treatment optimal response-adaptive designs for phase III clinical trials. Journal of the Korean Statistical Society 40 (1):33–44. doi:10.1016/j.jkss.2010.04.004.
   Web of Science ®Google Scholar
• Bowden, J., and E. Glimm. 2008. Unbiased estimation of selected treatment means in two-stage trials. Biometrical Journal 50 (4):515–527. doi:10.1002/bimj.200810442.
   PubMed Web of Science ®Google Scholar
• Bowden, J., and E. Glimm. 2014. Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials. Biometrical Journal 56 (2):332–349. doi:10.1002/bimj.201200245.
   PubMed Web of Science ®Google Scholar
• Brannath, W., E. Zuber, M. Branson, F. Bretz, P. Gallo, M. Posch, and A. Racine-Poon. 2009. Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology. Statistics in Medicine 28 (10):1445–1463. doi:10.1002/sim.3559.
   PubMed Web of Science ®Google Scholar
• Bretz, F., F. Koenig, W. Brannath, E. Glimm, and M. Posch. 2009. Adaptive designs for confirmatory clinical trials. Statistics in Medicine 28 (8):1181–1217. doi:10.1002/sim.3538.
   PubMed Web of Science ®Google Scholar
• Bretz, F., H. Schmidli, F. König, A. Racine, and W. Maurer. 2006. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: General concepts. Biometrical Journal 48 (4):623–634.
   PubMed Web of Science ®Google Scholar
• Chen, Y. J., R. Gesser, and A. Luxembourg. 2015. A seamless phase IIB/III adaptive outcome trial: design rationale and implementation challenges. Clinical Trials 12 (1):84–90. doi:10.1177/1740774514552110.
   PubMed Web of Science ®Google Scholar
• Chow, S. C. 2012. Adaptive design methods in clinical trials, second edition. . FL: Chapman and Hall/CRC, Boca raton.
   Google Scholar
• Cohen, A., and H. B. Sackrowitz. 1989. Two stage conditionally unbiased estimators of the selected mean. Statistics and Probability Letters 8 (3):273–278. doi:10.1016/0167-7152(89)90133-8.
   Web of Science ®Google Scholar
• Dunnett, C. W. 1955. A multiple comparison procedure for comparing several treatments with a control. Journal of the American Statistical Association 50 (272):1096–1121. doi:10.1080/01621459.1955.10501294.
   Web of Science ®Google Scholar
• Eisele, J. R., and M. B. Woodroofe. 1995. Central limit theorems for doubly adaptive biased coin designs. The Annals of Statistics 23:234–254. doi:10.1214/aos/1176324465.
   Web of Science ®Google Scholar
• Gwise, T., F. Hu, and J. Hu. 2008. Optimal biased coins for two-arm clinical trials. Statistics and Its Interface 1 (1):125–135. doi:10.4310/SII.2008.v1.n1.a11.
   Web of Science ®Google Scholar
• Hu, F., L. X. Zhang, and X. He. 2009. Efficient randomized-adaptive designs. The Annals of Statistics 37:2543–2560. doi:10.1214/08-AOS655.
   Web of Science ®Google Scholar
• Hu, F., and L.-X. Zhang. 2004. Asymptotic properties of doubly adaptive biased coin designs for multi-treatment clinical trials. The Annals of Statistics 32:268–301.
   Web of Science ®Google Scholar
• Hu, F., and W. F. Rosenberger. 2003. Optimality, variability, power: evaluating response-adaptive randomization procedures for treatment comparisons. Journal of the American Statistical Association 98 (463):671–678. doi:10.1198/016214503000000576.
   Web of Science ®Google Scholar
• Hu, F., and W. F. Rosenberger. 2006. The theory of response-adaptive randomization in clinical trials. New York: John Wiley and Sons, Inc.
   Google Scholar
• Hu, F., Y. Hu, W. Ma, L. Zhang, and H. Zhu. 2015. Statistical inference of adaptive randomized clinical trials for personalized medicine. Clinical Investigation 5 (4):415–425. doi:10.4155/cli.15.15.
   Google Scholar
• Huang, X., J. Ning, Y. Li, E. Estey, J. P. Issa, and D. A. Berry. 2009. Using short-term response information to facilitate adaptive randomization for survival clinical trials. Statistics in Medicine 28 (12):1680–1689. doi:10.1002/sim.3578.
   PubMed Web of Science ®Google Scholar
• Inoue, L. Y., P. F. Thall, and D. A. Berry. 2002. Seamlessly expanding a randomized phase II trial to phase III. Biometrics 58 (4):823–831.
   PubMed Web of Science ®Google Scholar
• Ivanova, A., and W. F. Rosenberger. 2000. A comparison of urn designs for randomized clinical trials of K > 2 treatments. Journal of Biopharmaceutical Statistics 10 (1):93–107. doi:10.1081/BIP-100101016.
   PubMedGoogle Scholar
• Kimani, P. K., S. Todd, and N. Stallard. 2013. Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility. Statistics in Medicine 32 (17):2893–2910. doi:10.1002/sim.5757.
   PubMed Web of Science ®Google Scholar
• Koenig, F., W. Brannath, F. Bretz, and M. Posch. 2008. Adaptive Dunnett tests for treatment selection. Statistics in Medicine 27 (10):1612–1625. doi:10.1002/sim.3048.
   PubMed Web of Science ®Google Scholar
• Koopmeiners, J. S., Z. Feng, and M. S. Pepe. 2012. Conditional estimation after a twostage diagnostic biomarker study that allows early termination for futility. Statistics in Medicine 31 (5):420–435. doi:10.1002/sim.4430.
   PubMed Web of Science ®Google Scholar
• Korn, E. L., B. Freidlin, J. S. Abrams, and S. Halabi. 2012. Design issues in randomized phase II/III trials. Journal of Clinical Oncology 30 (6):667–671. doi:10.1200/JCO.2011.38.5732.
   PubMed Web of Science ®Google Scholar
• Liu, Q., M. A. Proschan, and G. W. Pledger. 2002. A unified theory of two-stage adaptive designs. Journal of the American Statistical Association 97 (460):1034–1041. doi:10.1198/016214502388618852.
   Web of Science ®Google Scholar
• Marcus, R., P. Eric, and K. R. Gabriel. 1976. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 63 (3):655–660. doi:10.1093/biomet/63.3.655.
   Web of Science ®Google Scholar
• Müller, H. H., and H. Schäfer. 2001. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics 57 (3):886–891.
   PubMed Web of Science ®Google Scholar
• Posch, M., F. Koenig, M. Branson, W. Brannath, C. Dunger-Baldauf, and P. Bauer. 2005. Testing and estimation in flexible group sequential designs with adaptive treatment selection. Statistics in Medicine 24 (24):3697–3714. doi:10.1002/sim.2389.
   PubMed Web of Science ®Google Scholar
• Robertson, D. S., A. T. Prevost, and J. Bowden. 2016. Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesisdriven selection rules. Statistics in Medicine 35 (22):3907–3922. doi:10.1002/sim.6974.
   PubMed Web of Science ®Google Scholar
• Rosenberger, W. F., and J. M. Lachin. 2015. Randomization in clinical trials: theory and practice. John Wiley & Sons, Hoboken, NJ
   Google Scholar
• Rosenberger, W. F., N. Stallard, A. Ivanova, C. N. Harper, and M. L. Ricks. 2001. Optimal adaptive designs for binary response trials. Biometrics 57 (3):909–913.
   PubMed Web of Science ®Google Scholar
• Rout, C. C., D. A. Rocke, L. Levin, E. Gouws, and D. Reddy. 1993. A reevaluation of the role of crystalloid preload in the prevention of hypotension associated with apinal anesthesia for elective cesarean section. Anesthesiology 79:262–269. doi:10.1097/00000542-199308000-00011.
   PubMed Web of Science ®Google Scholar
• Sampson, A. R., and M. W. Sill. 2005. Drop-the-losers design: normal case. Biometrical Journal 47 (3):257–268.
   PubMed Web of Science ®Google Scholar
• Schaid, D. J., S. A. M. Wieand, and T. M. Therneau. 1990. Optimal two-stage screening designs for survival comparisons. Biometrika 77 (3):507–513. doi:10.1093/biomet/77.3.507.
   Web of Science ®Google Scholar
• Schmidli, H., F. Bretz, A. Racine, and W. Maurer. 2006. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations. Biometrical Journal 48 (4):635–643.
   PubMed Web of Science ®Google Scholar
• Schmoll, H., D. Cunningham, A. Sobrero, C. Karapetis, P. Rougier, S. L. Koski, P. Barker, B. Mookerjee, J. Robertson, and E. van Cutsem. 2010. mFOLFOX6 + cediranib vs mFOLFOX6 + bevacizumab in previously untreated metastatic colorectal cancer (MCRC): a randomised, doubleblind, phase II/III study (HORIZON III). Annals of Oncology 21:189. doi:10.1093/annonc/mdp513.
   PubMed Web of Science ®Google Scholar
• Shen, L. 2001. An improved method of evaluating drug effect in a multiple dose clinical trial. Statistics in Medicine 20 (13):1913–1929. doi:10.1002/sim.842.
   PubMed Web of Science ®Google Scholar
• Simes, R. J. 1986. An improved bonferroni procedure for multiple tests of significance. Biometrika 73 (3):751–754. doi:10.1093/biomet/73.3.751.
   Web of Science ®Google Scholar
• Stallard, N., and S. Todd. 2003. Sequential designs for phase III clinical trials incorporating treatment selection. Statistics in Medicine 22 (5):689–703. doi:10.1002/sim.1362.
   PubMed Web of Science ®Google Scholar
• Stallard, N., and S. Todd. 2005. Point estimates and confidence regions for sequential trials involving selection. Journal of Statistical Planning and Inference 135 (2):402–419. doi:10.1016/j.jspi.2004.05.006.
   Web of Science ®Google Scholar
• Stallard, N., and S. Todd. 2011. Seamless phase II/III designs. Statistical Methods in Medical Research 20 (6):623–634. doi:10.1177/0962280210379035.
   PubMed Web of Science ®Google Scholar
• Stallard, N., S. Todd, and J. Whitehead. 2008. Estimation following selection of the largest of two normal means. Journal of Statistical Planning and Inference 138 (6):1629–1638. doi:10.1016/j.jspi.2007.05.045.
   Web of Science ®Google Scholar
• Tamura, R. N., D. E. Faries, J. S. Andersen, and J. H. Heiligenstein. 1994. A case study of an adaptive clinical trial in the treatment of out-patients with depressive disorder. Journal of the American Statistical Association 89:768–776. doi:10.1080/01621459.1994.10476810.
   Web of Science ®Google Scholar
• Thall, P. F., and J. K. Wathen. 2007. Practical Bayesian adaptive randomisation in clinical trials. European Journal of Cancer 43 (5):859–866. doi:10.1016/j.ejca.2007.01.006.
   PubMed Web of Science ®Google Scholar
• Thall, P. F., R. Simon, and S. S. Ellenberg. 1988. Two-stage selection and testing designs for comparative clinical trials. Biometrika 75 (2):303–310. doi:10.1093/biomet/75.2.303.
   Web of Science ®Google Scholar
• Thall, P. F., R. Simon, and S. S. Ellenberg. 1989. A two-stage design for choosing among several experimental treatments and a control in clinical trials. Biometrics 45:537–547.
   PubMed Web of Science ®Google Scholar
• Troendle, J. F., and K. F. Yu. 1999. Conditional estimation following a group sequential clinical trial. Communications in Statistics-Theory and Methods 28 (7):1617–1634. doi:10.1080/03610929908832376.
   Web of Science ®Google Scholar
• Tymofyeyev, Y., W. F. Rosenberger, and F. Hu. 2007. Implementing optimal allocation in sequential binary response experiments. Journal of the American Statistical Association 102 (477):224–234. doi:10.1198/016214506000000906.
   Web of Science ®Google Scholar
• Wang, L., Y. Chen, and H. Zhu. 2017. Implementing optimal allocation in clinical trials with multiple endpoints. Journal of Statistical Planning and Inference 182:88–99. doi:10.1016/j.jspi.2016.09.002.
   PubMed Web of Science ®Google Scholar
• Wei, L. J., and S. Durham. 1978. The randomized play-the-winner rule in medical trials. Journal of the American Statistical Association 73:840–843. doi:10.1080/01621459.1978.10480109.
   Web of Science ®Google Scholar
• Yuan, Y., X. Huang, and S. Liu. 2011. A Bayesian responseadaptive covariatebalanced randomization design with application to a leukemia clinical trial. Statistics in Medicine 30 (11):1218–1229. doi:10.1002/sim.4218.
   PubMed Web of Science ®Google Scholar
• Zang, Y., and J. J. Lee. 2014. Adaptive clinical trial designs in oncology. Chinese Clinical Oncology 3 (4):49. doi:10.3978/j.issn.2304-3865.2014.06.02.
   Google Scholar
• Zeymer, U., H. Suryapranata, J. P. Monassier, G. Opolski, J. Davies, G. Rasmanis, G. Linssen, U. Tebbe, R. Schröder, R. Tiemann, et al. 2001. The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction: Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. Journal of the American College of Cardiology 38 (6):E1644–E1650. doi:10.1016/S0735-1097(01)01608-4.
   PubMed Web of Science ®Google Scholar
• Zhang, L. X., F. Hu, and S. H. Cheung. 2006. Asymptotic theorems of sequential estimation-adjusted urn models. The Annals of Applied Probability 16:340–369. doi:10.1214/105051605000000746.
   Web of Science ®Google Scholar
• Zhang, L.-X., F. Hu, S. H. Cheung, and W. S. Chan. 2007. Asymptotic properties of covariate-adjusted response-adaptive designs. The Annals of Statistics 35:1166–1182. doi:10.1214/009053606000001424.
   Web of Science ®Google Scholar
• Zhu, H. 2017. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions. Journal of Biopharmaceutical Statistics 27 (5):732–740. doi:10.1080/10543406.2016.1269780.
   PubMed Web of Science ®Google Scholar
• Zhu, H., and F. Hu. 2009. Implementing optimal allocation for sequential continuous responses with multiple treatments. Journal of Statistical Planning and Inference 139 (7):2420–2430. doi:10.1016/j.jspi.2008.11.003.
   Web of Science ®Google Scholar
• Zhu, H., and F. Hu. 2010. Sequential monitoring of response-adaptive randomized clinical trials. The Annals of Statistics 38:2218–2241. doi:10.1214/10-AOS796.
   Web of Science ®Google Scholar
• Zhu, H., and F. Hu. 2012. Interim analysis of clinical trials based on urn models. Canadian Journal of Statistics 40:550–568. doi:10.1002/cjs.v40.3.
   Web of Science ®Google Scholar